CMPX icon

Compass Therapeutics
CMPX

Overview Fund Activity

72 hedge funds and large institutions have $267M invested in Compass Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 7 closing their positions.

Holders
72
Holders Change
+17
Holders Change %
+30.91%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
24
Increased
26
Reduced
11
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
B
1
Braidwell
Connecticut
$10.6M
2
Millennium Management
2
Millennium Management
New York
$3.2M
3
PM
3
Prosight Management
Texas
$2.22M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$20.4M
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$2.56M

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$0
2
FCMV
2
Foresite Capital Management V
California
$11.4M
3
Alyeska Investment Group
3
Alyeska Investment Group
Illinois
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$18.6M
5
DCM
5
DAFNA Capital Management
California
$382K
Name Holding Trade Value Shares
Change 		Shares
Change %
Hudson Bay Capital Management
76
Hudson Bay Capital Management
Connecticut
– -$1.49M -311,500 Closed
SCM
77
Silverarc Capital Management
Massachusetts
– -$1.35M -268,307 Closed
MFS
78
Mirabella Financial Services
United Kingdom
– -$153K -30,444 Closed
Osaic Holdings
79
Osaic Holdings
Arizona
– -$1K -100 Closed
1 2 3
4